Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
September 6, 2012
|
August 2, 2012
|
July 18, 2012
|
June 20, 2012
|
|
June 15, 2012
|
June 15, 2012
|
June 11, 2012
|
June 8, 2012
|